Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299103 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles
A NA study of Appearance of Facial Wrinkles, sponsored by Ellman International.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01299103 is a NA study of Appearance of Facial Wrinkles that has completed, run by Ellman International. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01299103, a NA study of Appearance of Facial Wrinkles, has completed, sponsored by Ellman International.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will enroll and treat a patients to assess improvement in the appearance of facial wrinkles.
Conditions Studied
Interventions
- DEVICE Pelleve Wrinkle Treatment System
Study Locations (1)
Illinois
- DeNova Research Institute - Chichago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01299103
The ClinicalTrials.gov registry entry for NCT01299103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ellman International, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Appearance of Facial Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Pelleve Wrinkle Treatment System is the first listed.
NCT01299103 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01299103 about?
NCT01299103 is a clinical study titled "Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles". The study will enroll and treat a patients to assess improvement in the appearance of facial wrinkles.
What is the current status of trial NCT01299103?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-04. Estimated completion is 2012-04.
What conditions does trial NCT01299103 study?
This clinical trial studies the following conditions: Appearance of Facial Wrinkles.
What interventions are being tested in trial NCT01299103?
The interventions under investigation include: Pelleve Wrinkle Treatment System (DEVICE).
Who is sponsoring clinical trial NCT01299103?
This trial is sponsored by Ellman International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01299103 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.